Sanofi Aims to Be Pharma’s Top R&D Organization, Zerhouni Says

Sanofi, France’s biggest drugmaker, is advancing its overhaul of research and development, with the goal of becoming the industry leader in bringing new medicines to market, said Elias Zerhouni, the president of global R&D.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.